PRAGUE, May 10, 2011 /PRNewswire/ -- The congress of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association) is the biggest congress in Europe on nephrology and renal replacement therapy. You are cordially invited to attend this Congress.
The Opening Press Conference will be held on Thursday 23rd June, 11 am (Corinthia Hotel).
Topic: Can the high level of cardiovascular risk among the European population be reduced by improved kidney disease prevention?
Background: Cardiovascular disease is the main cause of death in Europe. New findings have shown that kidney diseases go hand in hand with cardiovascular disease. Reduced kidney function damages the heart and our circulation. WHO has therefore classified kidney disease as a high-risk factor.
On Friday 24th June, 11 am the Late Breaking Trials (LBT) - Press Briefing will be held.
Among the anticipated findings are the following:
- The CONTRAST study has been evaluating the outcome of high efficiency hemodiafiltration vs. low flux hemodialysis.
- The BEAM study investigated whether bardoxolone methyl can be used to stop loss of kidney function among patients with chronic kidney disease who are not yet on dialysis.
- The MASTERPLAN study evaluated whether strict implementation of current guidelines directed at multiple treatment targets with the help of a nurse practitioner improves cardiovascular outcome in CKD patients.
We look forward to your attending the Congress and would ask you for accreditation and/or your prior registration for the press briefing by email to email@example.com.
You find more information as well as an application form for partial reimbursement of your expenses (travel/hotel): http://www.eraedta2011.org/press.html
Dr. Bettina Albers DGfN Press Office Contact/ Press Office albersconcept Dr. Bettina Albers firstname.lastname@example.org Tel.: +49(0)3643-776423 Fax: +49(0)3643-776452